| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 59.74 | 0.00 (0.00%) | 44.84 - 60.22 | 300.0 (Below Avg) |
Market data as of 4:01PM 05/21/13. Quotes are delayed by at least 15 min.
| Open | -- |
|---|---|
| Previous Close | 59.74 |
| Day's Range | -- - -- |
| Market Cap | 10.8B |
| Avg Volume (10 Day) | 41.8K |
| Price/Earnings (Trailing 12 Mo.) | 15.2x |
| Earnings Per Share (Trailing 12 Mo.) | 3.94 |
| Dividend Yield | 0.81 (2.18%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Pass |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Pass |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Pass |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
No news headlines available for SNN
| SNN | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -3.75% | |
| Net Income Growth (1yr) | 13.92% | |
| Total Debt/Equity | 0.07 | |
| LT Debt/Equity | 0.05 | |
| Earnings Yield | 6.58% | |
| Price/Sales | 2.62 |
| Company | Last | Change |
|---|---|---|
| Boston Scientific Corp | 9.23 | 0.00% |
| St. Jude Medical Inc | 46.78 | 0.00% |
| Zimmer Holdings Inc | 81.01 | 0.00% |
| Varian Medical Systems Inc | 69.88 | 0.00% |
| Edwards Lifesciences Corp | 66.00 | 0.00% |
Data is delayed by at least 15 min.